Hydrocarbon-stapled polypeptides for enhancement of endosome-lysosomal degradation

Yanxiang Zhao; Shuai Wu; Wenchao Yang; Yunjiao He; Xiaohua Li; Xianxiu Qiu

Hydrocarbon-stapled polypeptides for enhancement of endosome-lysosomal degradation

Yanxiang Zhao (Inventor)
, Shuai Wu (Inventor)
, Wenchao Yang (Inventor)
, Yunjiao He (Inventor)
, Xiaohua Li (Inventor)
, Xianxiu Qiu (Inventor)

Department of Applied Biology and Chemical Technology

Research output: Patents, agreements, assignments and companies › Patents granted

Abstract

The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.

Original language	English
Patent number	US10618939
IPC	A61P35/00
Priority date	29/06/16
Filing date	14/03/18
Publication status	Published - 14 Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

More information

https://patentimages.storage.googleapis.com/91/69/08/e8f5c59f905638/US10618939.pdf

Cite this

@misc{95fb857129994b4d8e2c974e186a88a4,

title = "Hydrocarbon-stapled polypeptides for enhancement of endosome-lysosomal degradation",

abstract = "The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.",

author = "Yanxiang Zhao and Shuai Wu and Wenchao Yang and Yunjiao He and Xiaohua Li and Xianxiu Qiu",

year = "2020",

month = apr,

day = "14",

language = "English",

type = "Patent",

note = "US10618939; A61P35/00",

}

TY - PAT

T1 - Hydrocarbon-stapled polypeptides for enhancement of endosome-lysosomal degradation

AU - Zhao, Yanxiang

AU - Wu, Shuai

AU - Yang, Wenchao

AU - He, Yunjiao

AU - Li, Xiaohua

AU - Qiu, Xianxiu

PY - 2020/4/14

Y1 - 2020/4/14

N2 - The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.

AB - The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.

M3 - Patents granted

M1 - US10618939

Y2 - 2018/03/14

ER -

Hydrocarbon-stapled polypeptides for enhancement of endosome-lysosomal degradation

Abstract

UN SDGs

More information

Fingerprint

Cite this